Prediction of drug concentrations in milk during breastfeeding, integrating predictive algorithms within a physiologically‐based pharmacokinetic model
There is a risk of exposure to drugs in neonates during the lactation period due to maternal drug intake. The ability to predict drugs of potential hazards to the neonates would be useful in a clinical setting. This work aimed to evaluate the possibility of integrating milk‐to‐plasma (M/P) ratio pre...
Uloženo v:
| Vydáno v: | CPT: pharmacometrics and systems pharmacology Ročník 10; číslo 8; s. 878 - 889 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
John Wiley & Sons, Inc
01.08.2021
John Wiley and Sons Inc Wiley |
| Témata: | |
| ISSN: | 2163-8306, 2163-8306 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | There is a risk of exposure to drugs in neonates during the lactation period due to maternal drug intake. The ability to predict drugs of potential hazards to the neonates would be useful in a clinical setting. This work aimed to evaluate the possibility of integrating milk‐to‐plasma (M/P) ratio predictive algorithms within the physiologically‐based pharmacokinetic (PBPK) approach and to predict milk exposure for compounds with different physicochemical properties. Drug and physiological milk properties were integrated to develop a lactation PBPK model that takes into account the drug ionization, partitioning between the maternal plasma and milk matrices, and drug partitioning between the milk constituents. Infant dose calculations that take into account maternal and milk physiological variability were incorporated in the model. Predicted M/P ratio for acetaminophen, alprazolam, caffeine, and digoxin were 0.83 ± 0.01, 0.45 ± 0.05, 0.70 ± 0.04, and 0.76 ± 0.02, respectively. These ratios were within 1.26‐fold of the observed ratios. Assuming a daily milk intake of 150 ml, the predicted relative infant dose (%) for these compounds were 4.0, 6.7, 9.9, and 86, respectively, which correspond to a daily ingestion of 2.0 ± 0.5 mg, 3.7 ± 1.2 µg, 2.1 ± 1.0 mg, and 32 ± 4.0 µg by an infant of 5 kg bodyweight. Integration of the lactation model within the PBPK approach will facilitate and extend the application of PBPK models during drug development in high‐throughput screening and in different clinical settings. The model can also be used in designing lactation trials and in the risk assessment of both environmental chemicals and maternally administered drugs. |
|---|---|
| AbstractList | There is a risk of exposure to drugs in neonates during the lactation period due to maternal drug intake. The ability to predict drugs of potential hazards to the neonates would be useful in a clinical setting. This work aimed to evaluate the possibility of integrating milk-to-plasma (M/P) ratio predictive algorithms within the physiologically-based pharmacokinetic (PBPK) approach and to predict milk exposure for compounds with different physicochemical properties. Drug and physiological milk properties were integrated to develop a lactation PBPK model that takes into account the drug ionization, partitioning between the maternal plasma and milk matrices, and drug partitioning between the milk constituents. Infant dose calculations that take into account maternal and milk physiological variability were incorporated in the model. Predicted M/P ratio for acetaminophen, alprazolam, caffeine, and digoxin were 0.83 ± 0.01, 0.45 ± 0.05, 0.70 ± 0.04, and 0.76 ± 0.02, respectively. These ratios were within 1.26-fold of the observed ratios. Assuming a daily milk intake of 150 ml, the predicted relative infant dose (%) for these compounds were 4.0, 6.7, 9.9, and 86, respectively, which correspond to a daily ingestion of 2.0 ± 0.5 mg, 3.7 ± 1.2 µg, 2.1 ± 1.0 mg, and 32 ± 4.0 µg by an infant of 5 kg bodyweight. Integration of the lactation model within the PBPK approach will facilitate and extend the application of PBPK models during drug development in high-throughput screening and in different clinical settings. The model can also be used in designing lactation trials and in the risk assessment of both environmental chemicals and maternally administered drugs.There is a risk of exposure to drugs in neonates during the lactation period due to maternal drug intake. The ability to predict drugs of potential hazards to the neonates would be useful in a clinical setting. This work aimed to evaluate the possibility of integrating milk-to-plasma (M/P) ratio predictive algorithms within the physiologically-based pharmacokinetic (PBPK) approach and to predict milk exposure for compounds with different physicochemical properties. Drug and physiological milk properties were integrated to develop a lactation PBPK model that takes into account the drug ionization, partitioning between the maternal plasma and milk matrices, and drug partitioning between the milk constituents. Infant dose calculations that take into account maternal and milk physiological variability were incorporated in the model. Predicted M/P ratio for acetaminophen, alprazolam, caffeine, and digoxin were 0.83 ± 0.01, 0.45 ± 0.05, 0.70 ± 0.04, and 0.76 ± 0.02, respectively. These ratios were within 1.26-fold of the observed ratios. Assuming a daily milk intake of 150 ml, the predicted relative infant dose (%) for these compounds were 4.0, 6.7, 9.9, and 86, respectively, which correspond to a daily ingestion of 2.0 ± 0.5 mg, 3.7 ± 1.2 µg, 2.1 ± 1.0 mg, and 32 ± 4.0 µg by an infant of 5 kg bodyweight. Integration of the lactation model within the PBPK approach will facilitate and extend the application of PBPK models during drug development in high-throughput screening and in different clinical settings. The model can also be used in designing lactation trials and in the risk assessment of both environmental chemicals and maternally administered drugs. There is a risk of exposure to drugs in neonates during the lactation period due to maternal drug intake. The ability to predict drugs of potential hazards to the neonates would be useful in a clinical setting. This work aimed to evaluate the possibility of integrating milk‐to‐plasma (M/P) ratio predictive algorithms within the physiologically‐based pharmacokinetic (PBPK) approach and to predict milk exposure for compounds with different physicochemical properties. Drug and physiological milk properties were integrated to develop a lactation PBPK model that takes into account the drug ionization, partitioning between the maternal plasma and milk matrices, and drug partitioning between the milk constituents. Infant dose calculations that take into account maternal and milk physiological variability were incorporated in the model. Predicted M/P ratio for acetaminophen, alprazolam, caffeine, and digoxin were 0.83 ± 0.01, 0.45 ± 0.05, 0.70 ± 0.04, and 0.76 ± 0.02, respectively. These ratios were within 1.26‐fold of the observed ratios. Assuming a daily milk intake of 150 ml, the predicted relative infant dose (%) for these compounds were 4.0, 6.7, 9.9, and 86, respectively, which correspond to a daily ingestion of 2.0 ± 0.5 mg, 3.7 ± 1.2 µg, 2.1 ± 1.0 mg, and 32 ± 4.0 µg by an infant of 5 kg bodyweight. Integration of the lactation model within the PBPK approach will facilitate and extend the application of PBPK models during drug development in high‐throughput screening and in different clinical settings. The model can also be used in designing lactation trials and in the risk assessment of both environmental chemicals and maternally administered drugs. Abstract There is a risk of exposure to drugs in neonates during the lactation period due to maternal drug intake. The ability to predict drugs of potential hazards to the neonates would be useful in a clinical setting. This work aimed to evaluate the possibility of integrating milk‐to‐plasma (M/P) ratio predictive algorithms within the physiologically‐based pharmacokinetic (PBPK) approach and to predict milk exposure for compounds with different physicochemical properties. Drug and physiological milk properties were integrated to develop a lactation PBPK model that takes into account the drug ionization, partitioning between the maternal plasma and milk matrices, and drug partitioning between the milk constituents. Infant dose calculations that take into account maternal and milk physiological variability were incorporated in the model. Predicted M/P ratio for acetaminophen, alprazolam, caffeine, and digoxin were 0.83 ± 0.01, 0.45 ± 0.05, 0.70 ± 0.04, and 0.76 ± 0.02, respectively. These ratios were within 1.26‐fold of the observed ratios. Assuming a daily milk intake of 150 ml, the predicted relative infant dose (%) for these compounds were 4.0, 6.7, 9.9, and 86, respectively, which correspond to a daily ingestion of 2.0 ± 0.5 mg, 3.7 ± 1.2 µg, 2.1 ± 1.0 mg, and 32 ± 4.0 µg by an infant of 5 kg bodyweight. Integration of the lactation model within the PBPK approach will facilitate and extend the application of PBPK models during drug development in high‐throughput screening and in different clinical settings. The model can also be used in designing lactation trials and in the risk assessment of both environmental chemicals and maternally administered drugs. There is a risk of exposure to drugs in neonates during the lactation period due to maternal drug intake. The ability to predict drugs of potential hazards to the neonates would be useful in a clinical setting. This work aimed to evaluate the possibility of integrating milk‐to‐plasma (M/P) ratio predictive algorithms within the physiologically‐based pharmacokinetic (PBPK) approach and to predict milk exposure for compounds with different physicochemical properties. Drug and physiological milk properties were integrated to develop a lactation PBPK model that takes into account the drug ionization, partitioning between the maternal plasma and milk matrices, and drug partitioning between the milk constituents. Infant dose calculations that take into account maternal and milk physiological variability were incorporated in the model. Predicted M/P ratio for acetaminophen, alprazolam, caffeine, and digoxin were 0.83 ± 0.01, 0.45 ± 0.05, 0.70 ± 0.04, and 0.76 ± 0.02, respectively. These ratios were within 1.26‐fold of the observed ratios. Assuming a daily milk intake of 150 ml, the predicted relative infant dose (%) for these compounds were 4.0, 6.7, 9.9, and 86, respectively, which correspond to a daily ingestion of 2.0 ± 0.5 mg, 3.7 ± 1.2 µg, 2.1 ± 1.0 mg, and 32 ± 4.0 µg by an infant of 5 kg bodyweight. Integration of the lactation model within the PBPK approach will facilitate and extend the application of PBPK models during drug development in high‐throughput screening and in different clinical settings. The model can also be used in designing lactation trials and in the risk assessment of both environmental chemicals and maternally administered drugs. |
| Author | Jamei, Masoud Ning, Jia Abduljalil, Khaled Pansari, Amita |
| AuthorAffiliation | 1 Simcyp Division Certara UK Limited Sheffield UK |
| AuthorAffiliation_xml | – name: 1 Simcyp Division Certara UK Limited Sheffield UK |
| Author_xml | – sequence: 1 givenname: Khaled surname: Abduljalil fullname: Abduljalil, Khaled email: Khaled.Abduljalil@certara.com organization: Certara UK Limited – sequence: 2 givenname: Amita surname: Pansari fullname: Pansari, Amita organization: Certara UK Limited – sequence: 3 givenname: Jia surname: Ning fullname: Ning, Jia organization: Certara UK Limited – sequence: 4 givenname: Masoud surname: Jamei fullname: Jamei, Masoud organization: Certara UK Limited |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34213088$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstu1DAUhiNUREvphgdAkdggxBTfYjubSqjiUqkSIwFry3acjKeOHeyk1ex4BJY8H0-CZzJUbYXIxtE53_l0bP1PiwMfvCmK5xCcQgDQ2yEN5BQiStGj4ghBihccA3pw5_-wOElpDfLHCIA1eFIcYoIgBpwfFb-W0TRWjzb4MrRlE6eu1MFr48cot9VUWl_21l2VzRSt70oVjUxja_KY797k7mi6LZpbw951bUrpuhDtuOpTeZOP7JDlsNokG1zorJbObX7_-KlkMk2uy9hLHa6sN6PVZR8a454Vj1vpkjnZn8fFtw_vv55_Wlx-_nhx_u5yoSsO0YIwBaisWoixQYopJlGlGW40xLoGjSGNoi1pGUMQVKhFHJhaUS4pgTC3DT4uLmZvE-RaDNH2Mm5EkFbsCiF2Qsa8lTMCkAooU2PYspYArnlT0xrSStaMaaVYdp3NrmFSvWnmR3T3pPc73q5EF64Fx4xCVGfBq70ghu-TSaPobdLGOelNmJJAFeEEVpTjjL58gK7DFH1-qkxRVOEK8u1GL-5udLvK3wBk4PUM6BhSiqa9RSAQ24CJbcDELmAZBg9gbcddSvJtrPv3CJxHbqwzm__IxfLLkswzfwDjNObY |
| CitedBy_id | crossref_primary_10_3390_pharmaceutics15051469 crossref_primary_10_1002_cpt_2912 crossref_primary_10_1016_j_device_2025_100774 crossref_primary_10_1002_psp4_12802 crossref_primary_10_3390_ph17121654 crossref_primary_10_1002_jcph_2242 crossref_primary_10_1002_psp4_12865 crossref_primary_10_1002_psp4_13311 crossref_primary_10_1002_jcph_2284 crossref_primary_10_1016_j_fct_2022_112848 crossref_primary_10_1016_j_xphs_2025_103767 crossref_primary_10_3390_pharmaceutics15041228 crossref_primary_10_1002_prp2_70067 crossref_primary_10_3389_fphar_2024_1507551 crossref_primary_10_1002_psp4_13260 crossref_primary_10_3390_pharmaceutics15102467 crossref_primary_10_1136_bmjpo_2023_002385 crossref_primary_10_3389_fphar_2025_1517069 crossref_primary_10_3390_pharmaceutics16070847 crossref_primary_10_1016_j_fct_2024_114789 crossref_primary_10_1002_cpt_3059 crossref_primary_10_1371_journal_pntd_0011449 crossref_primary_10_1002_jcph_2455 crossref_primary_10_1002_psp4_70066 crossref_primary_10_1016_j_device_2025_100842 crossref_primary_10_1021_acsanm_5c01407 crossref_primary_10_1002_jcph_70093 crossref_primary_10_1002_phar_2732 crossref_primary_10_1002_bdd_2334 crossref_primary_10_3390_pharmaceutics15112618 crossref_primary_10_1002_bdd_2335 crossref_primary_10_1016_j_taap_2023_116495 crossref_primary_10_1002_psp4_13232 crossref_primary_10_1002_phar_2793 crossref_primary_10_1002_psp4_13252 crossref_primary_10_1002_psp4_13251 crossref_primary_10_1080_17425255_2025_2461479 crossref_primary_10_3389_fped_2022_840710 crossref_primary_10_1097_JCP_0000000000001873 crossref_primary_10_1080_17425255_2023_2221847 crossref_primary_10_1186_s12936_024_05112_9 crossref_primary_10_1007_s11095_023_03477_1 |
| Cites_doi | 10.1016/j.jpeds.2012.03.003 10.1542/peds.2005-1417 10.1289/ehp.0800047 10.1089/bfm.2006.1.79 10.1159/000457057 10.1016/0163-7258(93)90072-L 10.1002/jps.2600760302 10.1016/j.dmpk.2016.03.005 10.3389/fphar.2019.00005 10.3390/nu8120756 10.1186/1471-2431-14-216 10.1113/expphysiol.1993.sp003722 10.1111/j.1471-0528.1978.tb14929.x 10.1023/A:1016207832591 10.1016/j.jpba.2019.02.011 10.1016/j.envint.2016.03.015 10.1111/j.1365-2125.1995.tb05778.x 10.1007/BF00442328 10.1111/j.1365-2125.1995.tb04555.x 10.1007/s10928-020-09676-2 10.1136/adc.54.10.787 10.1093/toxsci/kfr141 10.1093/cdn/nzy025 10.1089/bfm.2019.0075 10.1542/peds.73.1.59 10.1177/0009922815594586 10.1016/S0022-3476(78)80391-6 10.1124/dmd.111.040972 10.2165/00003088-198814040-00003 10.1093/ajcn/54.1.69 10.1542/peds.78.3.458 10.1203/00006450-197712000-00002 10.1111/j.1365-2125.1988.tb03334.x 10.1111/j.1469-445X.1999.01808.x 10.1002/bod.2510090307 10.1177/089033402237904 10.1016/0009-9236(95)90175-2 10.1016/j.wombi.2017.12.004 10.1007/BF00607148 10.1038/clpt.2009.151 10.1093/ajcn/48.6.1375 10.1345/aph.1C379 10.1093/jat/bkw034 10.1016/j.biopha.2020.111038 10.2165/00003088-199018020-00005 10.1007/BF00613428 |
| ContentType | Journal Article |
| Copyright | 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics 2021 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. 2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics – notice: 2021 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. – notice: 2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1002/psp4.12662 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| DocumentTitleAlternate | Lactation PBPK model |
| EISSN | 2163-8306 |
| EndPage | 889 |
| ExternalDocumentID | oai_doaj_org_article_0450be931f7f408c8d969165a977cbb7 PMC8376129 34213088 10_1002_psp4_12662 PSP412662 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | 0R~ 1OC 24P 5VS 7X7 8FI 8FJ AAHHS AAZKR ABDBF ABUWG ACCFJ ACCMX ACGFS ACUHS ACXQS ADBBV ADKYN ADPDF ADRAZ ADZMN ADZOD AEEZP AEQDE AFKRA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU DIK EBS EJD FYUFA GODZA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH ITC KQ8 M48 M~E O9- OK1 OVD PIMPY PQQKQ PROAC RNTTT RPM TEORI TUS UKHRP WIN AAYXX AFFHD CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c5812-47b06a5f133e2b7b7a25c73dc13c90de4db6f4f7721052f280e9b68a64110dee3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 45 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000668946700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2163-8306 |
| IngestDate | Fri Oct 03 12:53:45 EDT 2025 Tue Nov 04 02:01:39 EST 2025 Fri Sep 05 11:21:28 EDT 2025 Tue Oct 07 07:13:08 EDT 2025 Mon Jul 21 05:24:13 EDT 2025 Tue Nov 18 22:28:45 EST 2025 Sat Nov 29 03:38:30 EST 2025 Wed Jan 22 16:57:06 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Language | English |
| License | Attribution-NonCommercial 2021 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5812-47b06a5f133e2b7b7a25c73dc13c90de4db6f4f7721052f280e9b68a64110dee3 |
| Notes | Funding information No funding was received for this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/0450be931f7f408c8d969165a977cbb7 |
| PMID | 34213088 |
| PQID | 2562535187 |
| PQPubID | 4368367 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_0450be931f7f408c8d969165a977cbb7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8376129 proquest_miscellaneous_2548415683 proquest_journals_2562535187 pubmed_primary_34213088 crossref_primary_10_1002_psp4_12662 crossref_citationtrail_10_1002_psp4_12662 wiley_primary_10_1002_psp4_12662_PSP412662 |
| PublicationCentury | 2000 |
| PublicationDate | August 2021 |
| PublicationDateYYYYMMDD | 2021-08-01 |
| PublicationDate_xml | – month: 08 year: 2021 text: August 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Hoboken |
| PublicationTitle | CPT: pharmacometrics and systems pharmacology |
| PublicationTitleAlternate | CPT Pharmacometrics Syst Pharmacol |
| PublicationYear | 2021 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
| References | 2012; 161 1978; 92 1987; 76 2002; 18 2009; 86 1991; 54 1995; 58 1990; 18 2019; 10 1988; 14 1986; 78 1995; 12 1985; 8 2019; 14 2016; 31 2003; 37 2019; 168 2006; 1 1999; 84 2011; 39 2006; 117 1979; 54 1981; 20 2016; 55 2009; 117 1993; 59 1984; 73 1995; 40 1993; 78 2018; 2 1988; 9 2016; 92–93 2021; 136 1988; 25 1978; 85 1988; 48 2014; 14 2020; 47 2016; 40 1977; 11 1982; 138 2014 2018; 31 1975; 9 2016; 8 2011; 122 e_1_2_10_23_1 e_1_2_10_46_1 e_1_2_10_21_1 e_1_2_10_44_1 e_1_2_10_42_1 e_1_2_10_40_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_6_1 e_1_2_10_16_1 Morriss FH (e_1_2_10_30_1) 1986; 78 e_1_2_10_39_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_48_1 e_1_2_10_24_1 e_1_2_10_45_1 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_20_1 e_1_2_10_41_1 e_1_2_10_3_1 e_1_2_10_19_1 Berlin CM (e_1_2_10_25_1) 1984; 73 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_31_1 e_1_2_10_50_1 Garessus EDG (e_1_2_10_49_1) 2019; 10 e_1_2_10_28_1 e_1_2_10_26_1 e_1_2_10_47_1 |
| References_xml | – volume: 40 start-page: 473 year: 2016 end-page: 477 article-title: Transfer of nicotine, cotinine and caffeine into breast milk in a smoker mother consuming caffeinated drinks publication-title: J Anal Toxicol – volume: 14 start-page: 217 year: 1988 end-page: 240 article-title: Drugs in human milk. Clinical pharmacokinetic considerations publication-title: Clin Pharmacokinet – volume: 54 start-page: 787 year: 1979 end-page: 789 article-title: Caffeine secretion into breast milk publication-title: Arch Dis Child – volume: 11 start-page: 1177 year: 1977 end-page: 1179 article-title: Electrolyte pH changes in human milk publication-title: Pediatr Res – volume: 8 start-page: 756 year: 2016 article-title: Breastmilk production in the first 4 weeks after birth of term infants publication-title: Nutrients – volume: 138 start-page: 49 year: 1982 end-page: 52 article-title: Kinetics of the translactal passage of digoxin from breast feeding mothers to their infants publication-title: Eur J Pediatr – volume: 9 start-page: 49 year: 1975 end-page: 55 article-title: Absorption of digoxin in infants publication-title: Eur J Clin Pharmacol – volume: 76 start-page: 189 year: 1987 end-page: 193 article-title: Factors affecting the milk‐to‐plasma drug concentration ratio in lactating women: physical interactions with protein and fat publication-title: J Pharm Sci – volume: 18 start-page: 151 year: 1990 end-page: 167 article-title: Prediction of drug distribution into human milk from physicochemical characteristics publication-title: Clin Pharmacokinet – volume: 59 start-page: 301 year: 1993 end-page: 310 article-title: Modelling of the passage of drugs into milk publication-title: Pharmacol Ther – volume: 25 start-page: 495 year: 1988 end-page: 503 article-title: Prediction of drug concentrations in human skim milk from plasma protein binding and acid‐base characteristics publication-title: Br J Clin Pharmacol – volume: 78 start-page: 458 year: 1986 end-page: 464 article-title: Relationship of human milk pH during course of lactation to concentrations of citrate and fatty acids publication-title: Pediatrics – volume: 55 start-page: 236 year: 2016 end-page: 244 article-title: A review of adverse reactions in infants from medications in breastmilk publication-title: Clin Pediatr (Phila) – volume: 117 start-page: e387 year: 2006 end-page: e395 article-title: Volume and frequency of breastfeedings and fat content of breast milk throughout the day publication-title: Pediatrics – volume: 85 start-page: 605 year: 1978 end-page: 609 article-title: Transfer of digoxin across the placenta and into breast milk publication-title: Br J Obstet Gynaecol – volume: 161 start-page: 448 year: 2012 end-page: 451 article-title: Neonatal benzodiazepines exposure during breastfeeding publication-title: J Pediatr – volume: 40 start-page: 333 year: 1995 end-page: 337 article-title: An in vitro technique for the rapid determination of drug entry into breast milk publication-title: Br J Clin Pharmacol – volume: 48 start-page: 1375 year: 1988 end-page: 1386 article-title: Studies in human lactation: milk volumes in lactating women during the onset of lactation and full lactation publication-title: Am J Clin Nutr – volume: 31 start-page: 362 year: 2018 end-page: 366 article-title: Why does the need for medication become a barrier to breastfeeding? A narrative review publication-title: Women Birth – volume: 58 start-page: 548 year: 1995 end-page: 555 article-title: Active transport of cimetidine into human milk publication-title: Clin Pharmacol Ther – year: 2014 – volume: 14 start-page: 216 year: 2014 article-title: A systematic review and meta‐analysis of the nutrient content of preterm and term breast milk publication-title: BMC Pediatr – volume: 8 start-page: 329 year: 1985 end-page: 337 article-title: Caffeine in human milk and in serum of breast‐fed infants publication-title: Dev Pharmacol Ther – volume: 92–93 start-page: 23 year: 2016 end-page: 32 article-title: An assessment of dioxin exposure across gestation and lactation using a PBPK model and new data from Seveso publication-title: Environ Int – volume: 18 start-page: 323 year: 2002 end-page: 332 article-title: Studying drugs in human milk: time to unify the approach publication-title: J Hum Lact – volume: 14 start-page: 508 year: 2019 end-page: 512 article-title: Exposures through breast milk: an analysis of exposure and information calls to U.S. poison centers, 2001–2017 publication-title: Breastfeed Med – volume: 39 start-page: 2370 year: 2011 end-page: 2380 article-title: Analysis and prediction of drug transfer into human milk taking into consideration secretion and reuptake clearances across the mammary epithelia publication-title: Drug Metab Dispos – volume: 122 start-page: 297 year: 2011 end-page: 316 article-title: Physiologically based pharmacokinetic modeling of fetal and neonatal manganese exposure in humans: describing manganese homeostasis during development publication-title: Toxicol Sci – volume: 20 start-page: 123 year: 1981 end-page: 125 article-title: Excretion of paracetamol in human breast milk publication-title: Eur J Clin Pharmacol – volume: 168 start-page: 83 year: 2019 end-page: 93 article-title: Quantification of eight benzodiazepines in human breastmilk and plasma by liquid‐liquid extraction and liquid‐chromatography tandem mass spectrometry: application to evaluation of alprazolam transfer into breastmilk publication-title: J Pharm Biomed Anal – volume: 92 start-page: 1019 year: 1978 end-page: 1020 article-title: Digoxin excretion in human breast milk publication-title: J Pediatr – volume: 73 start-page: 59 year: 1984 end-page: 63 article-title: Disposition of dietary caffeine in milk, saliva, and plasma of lactating women publication-title: Pediatrics – volume: 40 start-page: 231 year: 1995 end-page: 236 article-title: Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk publication-title: Br J Clin Pharmacol – volume: 54 start-page: 69 year: 1991 end-page: 80 article-title: Studies in human lactation: milk composition and daily secretion rates of macronutrients in the first year of lactation publication-title: Am J Clin Nutr – volume: 78 start-page: 741 year: 1993 end-page: 755 article-title: Degree of breast emptying explains changes in the fat content, but not fatty acid composition, of human milk publication-title: Exp Physiol – volume: 10 start-page: 5 year: 2019 article-title: Exposure of infants to isoniazid via breast milk after maternal drug intake of recommended doses is clinically insignificant irrespective of metaboliser status. A physiologically‐based pharmacokinetic (PBPK) modelling approach to estimate drug exposure of infants via breast‐feeding publication-title: Front Pharmacol – volume: 47 start-page: 295 year: 2020 end-page: 304 article-title: Clinical lactation studies and the role of pharmacokinetic modeling and simulation in predicting drug exposures in breastfed infants publication-title: J Pharmacokinet Pharmacodyn – volume: 31 start-page: 224 year: 2016 end-page: 233 article-title: Development of a permeability‐limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: estimating time varying CSF drug concentrations and their variability using in vitro data publication-title: Drug Metab Pharmacokinet – volume: 136 start-page: 111038 year: 2021 article-title: A comprehensive review on non‐clinical methods to study transfer of medication into breast milk ‐ a contribution from the ConcePTION project publication-title: Biomed Pharmacother – volume: 1 start-page: 79 year: 2006 end-page: 87 article-title: Accuracy of a user‐friendly centrifuge for measuring creamatocrits on mothers’ milk in the clinical setting publication-title: Breastfeed Med – volume: 2 start-page: nzy025 year: 2018 article-title: Human milk nutrient composition in the United States: current knowledge, challenges, and research needs publication-title: Curr Dev Nutr – volume: 86 start-page: 634 year: 2009 end-page: 643 article-title: Risk to the breast‐fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study publication-title: Clin Pharmacol Ther – volume: 37 start-page: 1299 year: 2003 end-page: 1306 article-title: Prediction of milk/plasma concentration ratio of drugs publication-title: Ann Pharmacother – volume: 12 start-page: 313 year: 1995 end-page: 316 article-title: Pharmacokinetics of caffeine and its demethylated metabolites in lactation: predictions of milk to serum concentration ratios publication-title: Pharm Res – volume: 9 start-page: 285 year: 1988 end-page: 299 article-title: Pharmacokinetics of caffeine in breast milk and plasma after single oral administration of caffeine to lactating mothers publication-title: Biopharm Drug Dispos – volume: 84 start-page: 435 year: 1999 end-page: 447 article-title: Breast volume and milk production during extended lactation in women publication-title: Exp Physiol – volume: 117 start-page: 481 year: 2009 end-page: 487 article-title: A physiologically based pharmacokinetic model for the assessment of infant exposure to persistent organic pollutants in epidemiologic studies publication-title: Environ Health Perspect – ident: e_1_2_10_36_1 doi: 10.1016/j.jpeds.2012.03.003 – ident: e_1_2_10_29_1 doi: 10.1542/peds.2005-1417 – ident: e_1_2_10_47_1 doi: 10.1289/ehp.0800047 – ident: e_1_2_10_15_1 doi: 10.1089/bfm.2006.1.79 – ident: e_1_2_10_39_1 doi: 10.1159/000457057 – ident: e_1_2_10_17_1 doi: 10.1016/0163-7258(93)90072-L – ident: e_1_2_10_13_1 doi: 10.1002/jps.2600760302 – ident: e_1_2_10_20_1 doi: 10.1016/j.dmpk.2016.03.005 – volume: 10 start-page: 5 year: 2019 ident: e_1_2_10_49_1 article-title: Exposure of infants to isoniazid via breast milk after maternal drug intake of recommended doses is clinically insignificant irrespective of metaboliser status. A physiologically‐based pharmacokinetic (PBPK) modelling approach to estimate drug exposure of infants via breast‐feeding publication-title: Front Pharmacol doi: 10.3389/fphar.2019.00005 – ident: e_1_2_10_28_1 doi: 10.3390/nu8120756 – ident: e_1_2_10_34_1 doi: 10.1186/1471-2431-14-216 – ident: e_1_2_10_33_1 doi: 10.1113/expphysiol.1993.sp003722 – ident: e_1_2_10_41_1 doi: 10.1111/j.1471-0528.1978.tb14929.x – ident: e_1_2_10_24_1 doi: 10.1023/A:1016207832591 – ident: e_1_2_10_35_1 doi: 10.1016/j.jpba.2019.02.011 – ident: e_1_2_10_46_1 doi: 10.1016/j.envint.2016.03.015 – ident: e_1_2_10_7_1 – ident: e_1_2_10_22_1 doi: 10.1111/j.1365-2125.1995.tb05778.x – ident: e_1_2_10_27_1 doi: 10.1007/BF00442328 – ident: e_1_2_10_38_1 doi: 10.1111/j.1365-2125.1995.tb04555.x – ident: e_1_2_10_3_1 doi: 10.1007/s10928-020-09676-2 – ident: e_1_2_10_37_1 doi: 10.1136/adc.54.10.787 – ident: e_1_2_10_48_1 doi: 10.1093/toxsci/kfr141 – ident: e_1_2_10_44_1 doi: 10.1093/cdn/nzy025 – ident: e_1_2_10_8_1 doi: 10.1089/bfm.2019.0075 – volume: 73 start-page: 59 year: 1984 ident: e_1_2_10_25_1 article-title: Disposition of dietary caffeine in milk, saliva, and plasma of lactating women publication-title: Pediatrics doi: 10.1542/peds.73.1.59 – ident: e_1_2_10_9_1 doi: 10.1177/0009922815594586 – ident: e_1_2_10_42_1 doi: 10.1016/S0022-3476(78)80391-6 – ident: e_1_2_10_16_1 doi: 10.1124/dmd.111.040972 – ident: e_1_2_10_10_1 doi: 10.2165/00003088-198814040-00003 – ident: e_1_2_10_31_1 doi: 10.1093/ajcn/54.1.69 – volume: 78 start-page: 458 year: 1986 ident: e_1_2_10_30_1 article-title: Relationship of human milk pH during course of lactation to concentrations of citrate and fatty acids publication-title: Pediatrics doi: 10.1542/peds.78.3.458 – ident: e_1_2_10_32_1 doi: 10.1203/00006450-197712000-00002 – ident: e_1_2_10_40_1 – ident: e_1_2_10_18_1 doi: 10.1111/j.1365-2125.1988.tb03334.x – ident: e_1_2_10_45_1 doi: 10.1111/j.1469-445X.1999.01808.x – ident: e_1_2_10_23_1 doi: 10.1002/bod.2510090307 – ident: e_1_2_10_5_1 doi: 10.1177/089033402237904 – ident: e_1_2_10_11_1 doi: 10.1016/0009-9236(95)90175-2 – ident: e_1_2_10_2_1 doi: 10.1016/j.wombi.2017.12.004 – ident: e_1_2_10_21_1 doi: 10.1007/BF00607148 – ident: e_1_2_10_50_1 doi: 10.1038/clpt.2009.151 – ident: e_1_2_10_19_1 doi: 10.1093/ajcn/48.6.1375 – ident: e_1_2_10_6_1 – ident: e_1_2_10_12_1 doi: 10.1345/aph.1C379 – ident: e_1_2_10_26_1 doi: 10.1093/jat/bkw034 – ident: e_1_2_10_4_1 doi: 10.1016/j.biopha.2020.111038 – ident: e_1_2_10_14_1 doi: 10.2165/00003088-199018020-00005 – ident: e_1_2_10_43_1 doi: 10.1007/BF00613428 |
| SSID | ssj0000740190 |
| Score | 2.4145439 |
| Snippet | There is a risk of exposure to drugs in neonates during the lactation period due to maternal drug intake. The ability to predict drugs of potential hazards to... Abstract There is a risk of exposure to drugs in neonates during the lactation period due to maternal drug intake. The ability to predict drugs of potential... |
| SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 878 |
| SubjectTerms | Adult Algorithms Babies Breast Feeding Breastfeeding & lactation Contraindications Data collection Drug development Drug dosages Drug therapy Female Humans Infant, Newborn Lactation Lipids Milk Milk, Human - chemistry Models, Biological Pharmaceutical industry Pharmaceutical Preparations - metabolism Pharmacokinetics Physicochemical properties Physiology Plasma Research Design Risk Assessment Young Adult |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELWgcODC90dKQUagSqANTRw7dk4IEBUHVEWioL1Fie1sV90m6Wa30t74CRz5ffwSZpxslhVVL9xWsTeaKM8zL-PxG0JelaGyAktxYm4CnxuVw5qTia9EHEUijLVxwvPfv8ijIzUeJ2mfcGv7ssq1T3SO2tQac-QHDJk6_FvJd825j12jcHe1b6FxndzAttmIczmWQ44lwHZzSTCokrKDpm342xCCEtuKQ06u_zKO-W-p5N8U1sWgwzv_a_1dcrtnn_R9B5d75Jqt7pP9tJOvXo3o8eY0Vjui-zTdCFuvHpBf6Ry3dfBV0rqkZr6cUI3HHqtee7el04qeTWentDv9SAsseV-UXYQc0bU2BQ41_b0uLM1nE7B1cXLWUkwLwz1y6jIua8c8W_3-8RPjrYHrnUWnwI7BSuo6-Twk3w4_HX_87PedHXwtgFH4XBZBnIsSPpAtK2Qhcya0jIwOI50ExnI8HMhLYP5A_1jJVGCTIlZ5zIGtGGujR2Snqiv7hFATicRqK4SyGv1RXuRaAsu1SpSCceuR1-v3nOle9hy7b8yyTrCZZYiJzGHCIy-HuU0n9nHprA8Il2EGCnS7C_V8kvXrPQOmHBQ2icJSljxQWpkkBiYucuDbuiikR_bWQMl6r9FmG5R45MUwDOsdN3HyytZLnMMVfnSryCOPO2wOlkScASVRyiNyC7Vbpm6PVNMTpymuINAA9fPIG4fvKx4_S7-m3P3avfoZnpJbDAuAXLXkHtlZzJf2GbmpLxbTdv7crdQ_o3RNYw priority: 102 providerName: ProQuest – databaseName: Wiley Online Library Open Access dbid: 24P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqwoEL70egICNQJdCmTRw7diQugKg4oCoSBfUWOY6zjbpNVslupb3xEzjy-_glzDjZLCsqJMRtFc9GtjyPz5OZz4S8LENlBZbixLwIfF4oDTYnE1-JOIpEGJvCEc9__SSPj9XpaZLukDfrXpieH2JMuKFlOH-NBq7z7nBDGjrv5vwghPgCDvhaGEYSdZrxdMywBHjZnEuyMAAdvgJwPPKTssPN37cikiPuvwpt_lk0-TuYddHo6Nb_reM2uTmgUPq2V5s7ZMfWd8l-2tNYryb0ZNOV1U3oPk03BNere-RH2uLnHdxS2pS0aJdTarD9sR44eDta1fSimp3TvguS5lj6vij7SDmha44KHJoP77q0VM-mTVstzi46iulheIemLvOydtCz1c9v3zHuFvC8n9E5rB9mSd2NPvfJl6MPJ-8_-sMND74RgCx8LvMg1qKEg7JlucylZsLIqDBhZJKgsBybBHkJJwCAgaxkKrBJHisdc0AthbXRA7JbN7V9RGgRicQaK4SyBv2SzrWRgHatEqVg3Hrk1XqXMzPQn-MtHLOsJ25mGW5E5jbCIy9G2XlP-nGl1DtUllECibrdg6adZoPdZ4CYg9wmUVjKkgfKqCKJAZELDbjb5Ln0yN5a1bLBe3QZw1MpWIqC4efjMNg9fszRtW2WKMMVHr5V5JGHvWaOM4k4A2iilEfkls5uTXV7pK7OHLe4goADENAjr53O_mX5Wfo55e7X438RfkJuMCwLcjWUe2R30S7tU3LdXC6qrn3mLPgXFhVNlA priority: 102 providerName: Wiley-Blackwell |
| Title | Prediction of drug concentrations in milk during breastfeeding, integrating predictive algorithms within a physiologically‐based pharmacokinetic model |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpsp4.12662 https://www.ncbi.nlm.nih.gov/pubmed/34213088 https://www.proquest.com/docview/2562535187 https://www.proquest.com/docview/2548415683 https://pubmed.ncbi.nlm.nih.gov/PMC8376129 https://doaj.org/article/0450be931f7f408c8d969165a977cbb7 |
| Volume | 10 |
| WOSCitedRecordID | wos000668946700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2163-8306 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000740190 issn: 2163-8306 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2163-8306 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000740190 issn: 2163-8306 databaseCode: M~E dateStart: 20120101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2163-8306 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000740190 issn: 2163-8306 databaseCode: BENPR dateStart: 20120901 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 2163-8306 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000740190 issn: 2163-8306 databaseCode: 7X7 dateStart: 20120901 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 2163-8306 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000740190 issn: 2163-8306 databaseCode: PIMPY dateStart: 20120901 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 2163-8306 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000740190 issn: 2163-8306 databaseCode: WIN dateStart: 20120101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2163-8306 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000740190 issn: 2163-8306 databaseCode: 24P dateStart: 20120101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELagcOCC-CdQVkagSqBNmzh27BwpakUlWEVQYDlFieO0UbfZVbJbaW88Akeejydhxsmmu6KCC5coia1okhl7Pjsz3xDysvCVERiKE_Lcc3muUhhzMnKVCINA-KHOLfH8l_dyNFLjcRSvlfrCmLCWHrj9cHsAObzMRIFfyIJ7Sqs8CgHSiBSAi84ym0fuyWhtMWXnYCw0F3k9HynbmzUzvuuDO2IbHsgS9V-FLv8MklwHr9b7HN4htzvYSN-04t4l10x1j-zELe_0ckiPL9OomiHdofElI_XyPvkZ1_g_BnVApwXN68UJ1ZivWHWkuQ0tK3peTs5om7ZIM4xVnxetaxvSFakENs26Z10Ymk5OpnU5Pz1vKO7nwjNSardKVjPqZPnr-w90lDncbyU6A1gLUlJbgucB-Xx4cPz2nduVZHC1ACjgcpl5YSoKWNkalslMpkxoGeTaD3Tk5YZjVh8vALIDbmMFU56JslClIQeYkRsTPCRb1bQyjwnNAxEZbYRQRuNEkmaplgBPjRKFYNw45NVKTYnu-MqxbMYkaZmWWYIqTaxKHfKi7ztrWTqu7LWP2u57ILO2vQH2lnT2lvzL3hyyvbKVpBvuTcJwGQmmraD5ed8MAxX_vqSVmS6wD1e4WlaBQx61ptVLEnAGWEIph8gNo9sQdbOlKk8tGbgCDwGYzSGvrXn-5fWT-FPM7dmT__EhnpJbDON7bDDkNtma1wvzjNzUF_OyqQfkOuMxHOVY2qMakBv7B6P448AOVLiKjz7E3-Dq69HoN5MbRd8 |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGQIIX7pfAACNgEqhhqWPHzgNC3KZNK1MlCupbSBynq9alpWmH-sZP4JFfwY_il3COcykV0972wFsVu5bjnMt37OPvEPIkaysjMBUn4Knn8lTFoHMydJUIfF-0A51a4vnPHbm_r_r9sLtGftV3YTCtsraJ1lCnY4175FsMkTr8W8lXk68uVo3C09W6hEYpFntm8Q1CtuLl7jv4vk8Z237fe7vjVlUFXC3Am7lcJl4QiwyCM8MSmciYCS39VLd9HXqp4XgxjWeAOgF6sIwpz4RJoOKAg6dMjfFh3HPkPNhxicGe7MtmT8fD8nah17Cgsq1JMeEv2uAE2Yrfs-UBTsK0_6Zm_g2Zrc_bvvK_rdZVcrlC1_R1qQ7XyJrJr5PNbknPvWjR3vK2WdGim7S7JO5e3CA_u1M8tkJRpeOMptP5gGq81plX3MIFHeb0aDg6pOXtTppgSv8sKxFAi9bcG9g0qcY6NjQeDWBtZgdHBcVtbxgjpnZHqXY8o8Xv7z8QT6TwvJzRIaB_mCW1lYpukk9nsmq3yHo-zs0dQlNfhEYbIZTRaG_jJNYSULxRIhOMG4c8q-Uq0hWtO1YXGUUlITWLUAYjK4MOedz0nZRkJif2eoPi2fRAAnL7YDwdRJU9iyAS8BIT-u1MZtxTWqVhAJGGiEErdJJIh2zUghlVVrGIllLpkEdNM9gzPKSKczOeYx-ucFNB-Q65XepCMxOfM4BcSjlErmjJylRXW_LhgeVMV-BIAdo65LnVp1NeP-p-7HL76-7p7_CQXNzpfehEnd39vXvkEsNkJ5sZukHWZ9O5uU8u6OPZsJg-sFaCki9nrWh_ADAfqRU |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLZGhxAv3C-BAUbAJFBDU8dOnAeEgDFRbVSRGGg8hcRxumpdWpp2qG_8BB75LfwcfgnnOJdSMe1tD7xVsWs5zrl8xz7-DiGPs67UAlNxPJ46Nk9lDDrnB7YUnuuKrqdSQzz_adfv9-X-fhCukV_1XRhMq6xtojHU6VjhHnmHIVKHf0u_k1VpEeHW9svJVxsrSOFJa11OoxSRHb34BuFb8aK3Bd_6CWPbb_fevLOrCgO2EuDZbO4njheLDAI1zRI_8WMmlO-mquuqwEk1x0tqPAMECjCEZUw6Okg8GXscvGaqtQvjniPrAMk5a5H1sPc-_Nzs8DhY7C5wGk5U1pkUE_68Cy6RrXhBUyzgJIT7b6Lm3wDaeMDty__z2l0hlyrcTV-VinKVrOn8GtkMS-LuRZvuLe-hFW26ScMlpffiOvkZTvFAC4WYjjOaTucDqvDCZ16xDhd0mNOj4eiQlvc-aYLJ_rOsxAZtWrNyYNOkGutY03g0gLWZHRwVFDfEYYyYmr2m2iWNFr-__0CkkcLzckaHEBfALKmpYXSDfDyTVbtJWvk417cJTV0RaKWFkFqhJY6TWPmA77UUmWBcW-RpLWORqgjfse7IKCqpqlmE8hgZebTIo6bvpKQ5ObHXaxTVpgdSk5sH4-kgqixdBDGCk-jA7WZ-xh2pZBp4EIOIGCINlSS-RTZqIY0qe1lESwm1yMOmGSwdHl_FuR7PsQ-XuN0gXYvcKvWimYnLGYAxKS3ir2jMylRXW_LhgWFTl-BiAfRa5JnRrVNePwo_hNz8unP6OzwgF0C_ot1ef-cuucgwC8qkjG6Q1mw61_fIeXU8GxbT-5XJoOTLWWvaHwyDs2Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prediction+of+drug+concentrations+in+milk+during+breastfeeding%2C+integrating+predictive+algorithms+within+a+physiologically%E2%80%90based+pharmacokinetic+model&rft.jtitle=CPT%3A+pharmacometrics+and+systems+pharmacology&rft.au=Khaled+Abduljalil&rft.au=Amita+Pansari&rft.au=Jia+Ning&rft.au=Masoud+Jamei&rft.date=2021-08-01&rft.pub=Wiley&rft.eissn=2163-8306&rft.volume=10&rft.issue=8&rft.spage=878&rft.epage=889&rft_id=info:doi/10.1002%2Fpsp4.12662&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_0450be931f7f408c8d969165a977cbb7 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2163-8306&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2163-8306&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2163-8306&client=summon |